Trademarks and Copyright© The images and information contained in the Site are, to the fullest extent possible, copyrighted and otherwise proprietary. It is the policy of Taro to enforce its intellectual property rights to the fullest extent of the law, including (where applicable) seeking criminal sanctions.

Site Search

Investor Relations

Corporate Profile Welcome to Taro’s Investor Relations Website Established in 1950, Taro Pharmaceutical Industries Ltd. is a research-based, international, specialty pharmaceutical company that develops, manufactures and markets prescription and over-the-counter pharmaceutical products. Taro’s research programs and niche strategy have enabled the Company to achieve leadership in dermatological products in the U.S. Growth Through Research Taro’s investments in research have enabled it to become a U.S. leader in topical prescription products (creams, ointments and gels). Approximately 1 in 8 tubes of such products sold in the U.S. are supplied by Taro. The Company also specializes in medicines used in cardiology, pediatrics and neurology. International Operations, U.S. Expansion Taro has research, manufacturin... More >>

TARO (Common Stock) Exchange NYSE (US Dollar) Price $63.97 Change (%)   1.11 (1.77%) Volume 32,917 Data as of 05/17/13 4:02 p.m. ET Click Here for Stock Quote Data on NYSE

Recent News

More >>

Date Title   05/16/13 Taro to Announce Results for Year Ended March 31, 2013 04/12/13 Taro Receives FDA Approval For Topicort® (desoximetasone) Topical Spray, 0.25% 02/08/13 Sun Pharma and Taro Announce Termination of Proposed Transaction

Quotes delayed at least 15 minutes. Market data provided by Interactive Data. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.